Endothelin-1 as a Mediator of Heme Oxygenase-1-Induced Stemness in Colorectal Cancer: Influence of p53

Endothelin-1 as a Mediator of Heme Oxygenase-1-Induced Stemness in Colorectal Cancer: Influence of p53

Heme oxygenase-1 (HO-1) is an antioxidant protein implicated in tumor progression, metastasis, and resistance to therapy. Elevated HO-1 expression is associated with stemness in several types of cancer, although this aspect has not yet been studied in colorectal cancer (CRC). Using an in vitro model...

Full description

Bibliographic Details
Main Authors:	Sandra Ríos-Arrabal, Jose D. Puentes-Pardo, Sara Moreno-SanJuan, Ágata Szuba, Jorge Casado, María García-Costela, Julia Escudero-Feliu, Michela Verbeni, Carlos Cano, Cristina González-Puga, Alicia Martín-Lagos Maldonado, Ángel Carazo, Josefa León
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Journal of Personalized Medicine
Subjects:	colorectal cancer cancer stem cells heme oxygenase-1 endothelin-1 endothelin con-verting enzyme-1 bosentan
Online Access:	https://www.mdpi.com/2075-4426/11/6/509

Similar Items

KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways
by: Shu-Fen Liou, et al.
Published: (2015-06-01)

Pharmacological Potential of Endothelin Receptors Agonists and Antagonists
by: Jiří Patočka, et al.
Published: (2005-01-01)

Role of the endothelin receptor antagonist bosentan in the treatment of patients with pulmonary hypertension
by: N A Tsareva
Published: (2013-12-01)

Blockade of Endothelin-1 Receptor Type B Ameliorates Glucose Intolerance and Insulin Resistance in a Mouse Model of Obstructive Sleep Apnea
by: Jan Polak, et al.
Published: (2018-05-01)

Endothelins: Vasoactive Peptids
by: Hasan Erdoğan, et al.
Published: (2013-08-01)

Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan
by: S N Avdeev
Published: (2015-09-01)

Circulating Levels of Endothelin-1 and Big Endothelin-1 in Patients with Essential Hypertension
by: Krasimir Kostov, et al.
Published: (2021-10-01)

Preventive role of endothelin antagonist on kidney ischemia: Reperfusion injury in male and female rats
by: Nazgol Esmalian Afyouni, et al.
Published: (2015-01-01)

Bosentan, a drug used in the treatment of pulmonary hypertension, can prevent development of osteoporosis
by: Duygu Köse, et al.
Published: (2021-07-01)

First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study
by: S N Avdeev, et al.
Published: (2013-03-01)

Heme Oxygenase-1 in Gastrointestinal Tract Health and Disease
by: Jose D. Puentes-Pardo, et al.
Published: (2020-12-01)

Endothelin-converting enzyme-1 expression in acute and chronic liver injury in fibrogenesis
by: Tae-Jun Cho, et al.
Published: (2019-05-01)

Endothelin-1 Induces Cell Proliferation and Myofibroblast Differentiation through the ET<sub>A</sub>R/G<sub>αq</sub>/ERK Signaling Pathway in Human Cardiac Fibroblasts
by: Ratchanee Duangrat, et al.
Published: (2023-02-01)

Expression of Endothelin-1, Endothelin Receptor-A, and Endothelin Receptor-B in facial melasma compared to adjacent skin
by: da Silva CN, et al.
Published: (2023-10-01)

Labile Heme and Heme Oxygenase-1 Maintain Tumor-Permissive Niche for Endometriosis-Associated Ovarian Cancer
by: Jonathan L. Hecht, et al.
Published: (2022-04-01)

Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial
by: Pierluigi Carratù, et al.
Published: (2019-09-01)

Current status of bosentan for treatment of pulmonary hypertension
by: Raja Shahzad, et al.
Published: (2008-01-01)

The effect and mechanism of endothelin-1-induced intracellular free calcium in human lung adenocarcinoma cells SPC-A1
by: Juan ZHOU, et al.
Published: (2008-08-01)

PLASMA CONCENTRATION OF ENDOTHELIN-1 IN PATIENTS WITH HYPERTENSION ASSOCIATED WITH OBESITY, DEPENDING ON THE LYS198ASN POLYMORPHISM OF THE ENDOTHELIN-1 GENE
by: Yu. O. Smiianova
Published: (2021-03-01)

Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury
by: Maria G. Detsika, et al.
Published: (2021-01-01)

Heme Oxygenase 1: A Defensive Mediator in Kidney Diseases
by: Anne Grunenwald, et al.
Published: (2021-02-01)

Pharmacological Significance of Heme Oxygenase 1 in Prostate Cancer
by: Mohamed Ben-Eltriki, et al.
Published: (2023-05-01)

Endothelin-1 receptor antagonists protect the kidney against the nephrotoxicity induced by cyclosporine-A in normotensive and hypertensive rats
by: A. Caires, et al.
Published: (2017-12-01)

An emerging role for microRNA in the regulation of endothelin-1
by: Mollie E Jacobs, et al.
Published: (2013-02-01)

Evaluation of the Expression Levels of Endothelin-1 and its Receptor (ETAR) in Dental Lamina during Different Stages of Development of Human Fetal Teeth
by: Soussan Irani, et al.
Published: (2021-09-01)

Heme oxygenase-1 and carbon monoxide in pulmonary medicine
by: Choi Augustine MK, et al.
Published: (2003-08-01)

Effect of bosentan on intimal hyperplasia of carotid artery anastomoses in rabbits
by: Artan Jahollari, et al.
Published: (2014-02-01)

Breast cancer diagnosis is associated with relative left ventricular hypertrophy and elevated endothelin-1 signaling
by: Zaid H. Maayah, et al.
Published: (2020-08-01)

Targeting Endothelin-1 Receptor/β-Arrestin-1 Axis in Ovarian Cancer: From Basic Research to a Therapeutic Approach
by: Piera Tocci, et al.
Published: (2019-09-01)

Clinical and molecular analysis of a novel variant in heme oxygenase-1 deficiency: Unraveling its role in inflammation, heme metabolism, and pulmonary phenotype
by: Lea-Sophie Berendes, et al.
Published: (2024-03-01)

ET-1 and cytokines in airway inflammation
by: Page Kristen, et al.
Published: (2001-04-01)

Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1
by: Yang Jiao, et al.
Published: (2018-10-01)

Immune Regulation of Heme Oxygenase-1 in Allergic Airway Inflammation
by: Zhenwei Xia, et al.
Published: (2022-02-01)

Heme Oxygenase 1‐Targeted Hybrid Nanoparticle for Chemo‐ and Immuno‐Combination Therapy in Acute Myelogenous Leukemia
by: Seok‐Beom Yong, et al.
Published: (2020-07-01)

Upregulation of Endothelin-1/Endothelin A Receptor Expression Correlates with Heparanase Expression in Ovarian Carcinoma
by: Nungki Anggorowati, et al.
Published: (2018-05-01)

Elevated Endothelin-1 in Intradialytic Hypertension
by: Rubin Surachno Gondodiputro, et al.
Published: (2019-09-01)

Endothelin‐converting enzyme‐1c promotes stem cell traits and aggressiveness in colorectal cancer cells
by: Pablo Pérez‐Moreno, et al.
Published: (2020-02-01)

Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?
by: Correale M, et al.
Published: (2018-10-01)

Skeletal muscle heme oxygenase-1 activity regulates aerobic capacity
by: Rodrigo W. Alves de Souza, et al.
Published: (2021-04-01)

Endothelin-based markers for endothelial dysfunction in chemotherapy-induced cardiotoxicity
by: Gabrielle Boutin, et al.
Published: (2023-12-01)